Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,401
Closed -$644K 78
2021
Q4
$644K Sell
8,401
-89
-1% -$7.09K 0.36% 50
2021
Q3
$638K Sell
8,490
-86
-1% -$6.54K 0.38% 49
2021
Q2
$667K Sell
8,576
-412
-5% -$30.6K 0.39% 48
2021
Q1
$661K Hold
8,988
0.41% 48
2020
Q4
$702K Sell
8,988
-1,607
-15% -$123K 0.43% 40
2020
Q3
$839K Buy
10,595
+36
+0.3% +$2.82K 0.58% 34
2020
Q2
$779K Sell
10,559
-627
-6% -$47.2K 0.55% 35
2020
Q1
$821K Sell
11,186
-89
-0.8% -$7K 0.67% 29
2019
Q4
$979K Hold
11,275
0.62% 31
2019
Q3
$906K Sell
11,275
-65
-0.6% -$5.21K 0.62% 32
2019
Q2
$907K Sell
11,340
-236
-2% -$18.1K 0.62% 31
2019
Q1
$919K Buy
11,576
+891
+8% +$66.6K 0.64% 31
2018
Q4
$779K Hold
10,685
0.63% 31
2018
Q3
$723K Sell
10,685
-79
-0.7% -$5.03K 0.48% 35
2018
Q2
$623K Sell
10,764
-210
-2% -$11.8K 0.48% 35
2018
Q1
$570K Sell
10,974
-104
-0.9% -$5.62K 0.44% 39
2017
Q4
$595K Sell
11,078
-407
-4% -$22.6K 0.44% 39
2017
Q3
$702K Sell
11,485
-367
-3% -$22.3K 0.56% 31
2017
Q2
$725K Hold
11,852
0.59% 30
2017
Q1
$719K Buy
11,852
+419
+4% +$25.4K 0.6% 29
2016
Q4
$642K Hold
11,433
0.58% 33
2016
Q3
$681K Sell
11,433
-209
-2% -$12.2K 0.63% 28
2016
Q2
$640K Hold
11,642
0.61% 31
2016
Q1
$588K Hold
11,642
0.57% 34
2015
Q4
$587K Sell
11,642
-1,066
-8% -$53.7K 0.58% 32
2015
Q3
$599K Hold
12,708
0.62% 28
2015
Q2
$690K Sell
12,708
-105
-0.8% -$5.89K 0.65% 27
2015
Q1
$703K Sell
12,813
-698
-5% -$39.5K 0.65% 26
2014
Q4
$732K Sell
13,511
-298
-2% -$16.6K 0.67% 24
2014
Q3
$781K Sell
13,809
-1,085
-7% -$60.9K 0.74% 23
2014
Q2
$822K Sell
14,894
-262
-2% -$14.3K 0.77% 23
2014
Q1
$821K Sell
15,156
-316
-2% -$16.4K 0.79% 23
2013
Q4
$739K Buy
+15,472
New +$707K 0.72% 23

Other funds holding MRK

Elm Advisors's MRK Position: Q1 2022 in Review

Elm Advisors sold out of Merck (MRK) in Q1 2022, closing a stake of 8,401 shares — an estimated $644K sold.

Elm Advisors first reported a position in MRK in Q4 2013 and held it in 33 quarters. The position peaked at $979K in Q4 2019. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Elm Advisors reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Elm Advisors sold 8,401 Merck shares in Q1 2022, an estimated $644K.
  • Elm Advisors first reported a position in Merck in Q4 2013 and held it in 33 quarters.
  • Elm Advisors's Merck position peaked at $979K in Q4 2019.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Elm Advisors's 13F filing for Q1 2022, filed 1 Apr 2022.